Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV disease.
about
Human CMV-specific T-cell responses in kidney transplantation; toward changing current risk-stratification paradigmState-of-the-art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplant: a primer for the clinicianFlow cytometry and solid organ transplantation: a perfect matchProgrammed death-1 receptor and interleukin-10 in liver transplant recipients at high risk for late cytomegalovirus diseasePrimary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipientsA multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)-specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograftHumoral and cellular CMV responses in healthy donors; identification of a frequent population of CMV-specific, CD4+ T cells in seronegative donorsCurrent concepts on cytomegalovirus infection after liver transplantationAn analysis of regulatory T-cell and Th-17 cell dynamics during cytomegalovirus replication in solid organ transplant recipientsHuman cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells are both required for prevention of HCMV disease in seropositive solid-organ transplant recipients.Primary cytomegalovirus phosphoprotein 65-specific CD8+ T-cell responses and T-bet levels predict immune control during early chronic infection in lung transplant recipients.Dynamics of cell-mediated immune responses to cytomegalovirus in pediatric transplantation recipientsClinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant.Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy.CD28 family and chronic rejection: "to belatacept...And beyond!".Preformed frequencies of cytomegalovirus (CMV)-specific memory T and B cells identify protected CMV-sensitized individuals among seronegative kidney transplant recipients.Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant RecipientsA HCMV pp65 polypeptide promotes the expansion of CD4+ and CD8+ T cells across a wide range of HLA specificities.Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients.A fusion protein of HCMV IE1 exon4 and IE2 exon5 stimulates potent cellular immunity in an MVA vaccine vector.Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation.A novel approach to evaluate the immunogenicity of viral antigens of clinical importance in HLA transgenic murine models.Cytomegalovirus-associated chorioretinitis after liver transplantation: case report and review of the literature.Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS.Differential CMV-specific CD8+ effector T cell responses in the lung allograft predominate over the blood during human primary infectionThe Association Between Viral Infections and Co-stimulatory Gene Polymorphisms in Kidney Transplant Outcomes.Increased programmed death-1 molecule expression in cytomegalovirus disease and acute graft-versus-host disease after allogeneic hematopoietic cell transplantationImmunological risk factors for infection after immunosuppressive and biologic therapies.Advances in cytomegalovirus-preventive strategies in solid organ transplantation: defending pre-emptive therapy.Immune-based monitoring for cytomegalovirus infection in solid organ transplantation: is it ready for clinical primetime?Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation.In vitro cell-mediated immune responses of human immunodeficiency virus-infected and -uninfected individuals to whole cytomegalovirus antigens and their subunits.Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.Association of the costimulatory molecule gene polymorphisms and active cytomegalovirus infection in hematopoietic stem cell transplant patients.Immunological Prediction of Cytomegalovirus (CMV) Replication Risk in Solid Organ Transplantation Recipients: Approaches for Regulating the Targeted Anti-CMV Prevention Strategies.Cytomegalovirus infection after liver transplantation: current concepts and challenges.Pretransplant immediately early-1-specific T cell responses provide protection for CMV infection after kidney transplantation.Simultaneous Monitoring of Cytomegalovirus-Specific Antibody and T-cell levels in Seropositive Heart Transplant Recipients
P2860
Q26850340-F2C874F4-225A-40D5-AC15-67D8512D5EB3Q27014778-B9FD123B-B89D-4C74-AB67-7AAF1747D2D6Q27026499-23D05C9D-6690-4039-A714-C2F0296338F0Q33523611-B29F2F1E-0317-431A-8350-A863D0967BA2Q33932079-48DD68FE-AF33-41E6-B90A-DB1F7701C94AQ34105900-E355BE62-59C9-4633-B0E4-4B9E4262221EQ34162822-6B39EA3B-C7A3-49F5-9FF2-DF62BBF74603Q34390310-7F74191F-48C8-479B-A93D-7556863F32FBQ34448341-C953E22E-B1BF-4BBC-8263-1BB6C3DD704EQ35233773-DC2601D2-0099-49E6-88FB-86B5B6FA6355Q35463623-0B572E4F-F858-46A5-B372-F1C90BB540FCQ35544428-76741338-A497-4218-B091-6E608496D7BAQ35842287-698C829B-3527-4F12-8D8B-24FD53B0ECDCQ35895301-0CF4C963-038C-47F7-BFBD-F5ABD870A0C1Q36037639-B27F4B78-D478-4BD2-82CB-88A4672136B9Q36293963-8054A9B2-3CF5-40C6-A225-FC50C6CDF98CQ36389162-F52F5CC4-A6F0-49B6-85D0-BC3957F664D1Q36547317-9348248E-FA00-4B83-9B9A-05D8B0770988Q36728782-752BE9B7-AA3A-4F95-B96D-5C60FF46CFBAQ36824066-7E9D30C0-7732-4840-A621-0E7C4801E364Q36933904-87E352F0-B483-459B-B0DC-216EAC2F332CQ36960608-0A024C57-70C3-4EDF-AF09-E25D0048B12DQ37034498-A11EF331-CD8D-4F7B-BB66-1EC677FC9B64Q37151478-7EAB6EBB-722D-428C-8874-AACEC95B2FB5Q37157642-43E00DE0-80A0-43A3-A0E0-DD4B9850E59CQ37361121-AD6FBA92-6975-454D-8D05-BC81B1AAE591Q37391085-B0E8EE06-10B5-475F-8AF9-E0ACCA29766CQ37866813-E9B4BD41-3F8A-4EDB-9577-E7B7F5F947EEQ37965695-DA40B762-B3BC-456B-B161-C40ED827F711Q38235723-33A6E2F4-B095-45FC-9A57-B5A1A8A1ACD0Q40115981-0A26FC50-D9A4-4E6C-BE3D-2C46A3FDA0B7Q41810722-F08D8C53-A0CD-468E-84AC-926962846A6BQ42208965-F6A8FC9C-C698-4931-B933-AC5B97A993D4Q42267746-28F17373-C5A8-4874-BF3C-05E79BE4F691Q42366690-9CBE9AF6-A5E5-4F35-9BD6-5230F4537152Q42549311-715CAE52-1C88-402D-9FD2-48A11C3D8C4FQ43653857-974ADF69-07C9-43DD-9C57-D14888D185B5Q57568998-0C2330F3-739D-41A8-9412-943BC830A1AE
P2860
Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV disease.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Longitudinal assessment of cyt ...... igh risk for late CMV disease.
@ast
Longitudinal assessment of cyt ...... igh risk for late CMV disease.
@en
Longitudinal assessment of cytomegalovirus
@nl
type
label
Longitudinal assessment of cyt ...... igh risk for late CMV disease.
@ast
Longitudinal assessment of cyt ...... igh risk for late CMV disease.
@en
Longitudinal assessment of cytomegalovirus
@nl
prefLabel
Longitudinal assessment of cyt ...... igh risk for late CMV disease.
@ast
Longitudinal assessment of cyt ...... igh risk for late CMV disease.
@en
Longitudinal assessment of cytomegalovirus
@nl
P2093
P356
P1476
Longitudinal assessment of cyt ...... igh risk for late CMV disease.
@en
P2093
Ajit P Limaye
Aparna Krishnan
Corinna La Rosa
Jeff Longmate
P304
P356
10.1086/511307
P407
P577
2007-01-22T00:00:00Z